Inhibikase Therapeutics to Present at the International Congress of Parkinson's Disease and Movement Disorders
BOSTON and ATLANTA, Aug. 22, 2023 /PRNewswire/ -- Inhibikase Therapeutics, Inc. , a clinical-stage pharmaceutical company developing protein kinase inhibitor therapeutics to modify the course of...